Andrew Prigodich is a highly accomplished scientist and healthcare executive. Holding a PhD in Nanotechnology, Biology, and Chemistry from Northwestern University, as well as degrees in Biological Chemistry and Biochemistry from Bates College and Brandeis University, respectively, he has a wealth of experience in the biotech and pharmaceutical industries.

Currently serving as Senior Director of R&D Strategy at Pfizer, Andrew has held various positions throughout his career, having previously served as an Associate Director at Shire Pharmaceuticals and as a consultant at The Boston Consulting Group. Andrew has also worked as an Associate in Biotechnology Equity Research at JMP Group and as a Research Technician at the Sanford-Burnham Medical Research Institute.

Andrew's expertise spans research and development, strategic planning, equity research, and management consulting in the life sciences industry. His experience in both biotech and pharma companies and his work as a consultant make him well-versed in the intricacies of drug development and commercialization, as well as in strategic decision-making and business development.

Overall, Andrew Prigodich is a talented and experienced scientist and executive whose expertise in the life sciences industry makes him a valuable addition to any team.